2021
Immune Checkpoint Inhibitor–associated Diarrhea and Colitis: A Systematic Review and Meta-analysis of Observational Studies
Tran AN, Wang M, Hundt M, Chugh R, Ohm J, Grimshaw A, Ciarleglio M, Hung KW, Proctor DD, Price CC, Laine L, Al-Bawardy B. Immune Checkpoint Inhibitor–associated Diarrhea and Colitis: A Systematic Review and Meta-analysis of Observational Studies. Journal Of Immunotherapy 2021, 44: 325-334. PMID: 34380976, DOI: 10.1097/cji.0000000000000383.Peer-Reviewed Original ResearchConceptsImmune checkpoint inhibitorsDiarrhea/colitisICI therapyCheckpoint inhibitorsObservational studyAnti-programmed cell death-1/Outcomes of ICISystematic reviewCell death-1/Permanent ICI discontinuationReal-world incidenceRemission of diarrheaRecurrence of symptomsDeath-1/Treatment of diarrheaRandom-effects modelICI discontinuationAdvanced malignanciesAppropriate patientsPrimary outcomeOverall incidenceAntigen-4Early treatmentColitisHigh risk
2004
The epidemiology of ischaemic colitis
Higgins PD, Davis KJ, Laine L. The epidemiology of ischaemic colitis. Alimentary Pharmacology & Therapeutics 2004, 19: 729-738. PMID: 15043513, DOI: 10.1111/j.1365-2036.2004.01903.x.Peer-Reviewed Original ResearchConceptsIschemic colitisRisk factorsPopulation-based sampleGeneral populationPopulation incidenceChronic obstructive pulmonary diseaseCo-morbid conditionsIrritable bowel syndromeObstructive pulmonary diseasePopulation-based studyGeneral population incidenceBowel syndromePulmonary diseaseCase seriesBaseline incidenceCase reportAdvanced ageVascular surgeryColitisEligible articlesIncidencePopulation samplePrevalenceRiskBibliographic databases